Home
IP public policy

Work Area: IP public policy

Moderna says US government on the hook to pay any royalties due to mRNA patent owners

The company claims any infringing uses of its vaccine are insulated from liability under compulsory licensing law

Qualcomm chief IP counsel: US IP system in decent shape but some current proposals could be “detrimental”

Bob Giles, top IP lawyer for the San Diego chip innovator, also says standards-setting process works well, downplaying concerns that it is being gamed

Japan passes sweeping economic security law including patent secrecy system

Major companies must now figure out how to maintain compliance with the new measures in IP and other areas

Latest content

Landmark Dutch appeal court decision reduces risk of third-party damages against pharma patentees

The appellate ruling overturns a recent lower court judgment which exposed life sciences IP plaintiffs to significant additional dangers from health insurer lawsuits

06 January 2022

How looming patent cliffs are impacting pharma IP strategies

Major IP expiries on the horizon are not only shaping pharma dealmaking patterns, but are likely to lead to further patent thicket disputes.

05 January 2022

Huawei inks its first Wi-Fi 6 patent licence with an overseas implementer

Latest patent deals related to the next-gen wireless internet standard suggest patent owners spy monetisation opportunities

04 January 2022

What’s ahead for the global IP market in 2022

Predictions from the IAM editorial team on what the next twelve months have in store

03 January 2022

The US's biggest patent stories of 2021

Kathi Vidal, Ericsson, Arthrex and Judge Alan Albright were among the names that made the IP headlines over the course of the year

23 December 2021

The top five patent stories in Europe during 2021

New German legislation, a leap forward on the UPC and important SEP-related initiatives from the UK and the Commission were among the highlights of a busy year

23 December 2021

Data sheds light on patenting strategies in the self-driving vehicle space

Landscape analysis reveals a space where automakers, suppliers and tech companies are all active and portfolio strategies are largely focused on one or two jurisdictions

22 December 2021

The biggest biopharma patent stories of the year

From President Biden’s backing for a covid IP waiver through a new linkage system in China to big changes in Brazil, it was an action-packed 2021 for the life sciences industries

21 December 2021

The biggest Asia-Pacific IP stories of 2021

Beyond China, there was a lot going on in a market that is home to some of the world’s most important patent-producing businesses

21 December 2021

The most important patent and IP business developments in China in 2021

A wide-ranging overhaul of the law, big moves on FRAND and a major departure were among the highlights of a busy year

20 December 2021

Get unlimited access to all IAM content